Inventor
Margaretha Henrica Maria Bakker
Inventor
Ludwigshafen, DE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations42%
A61KPreparations for medical, dental or toiletry purposes12%
PatentTitleYear
10,118,926Tricyclic quinoline and quinoxaline derivatives201810,100,048Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors20189,994,568Tricyclic quinoline and quinoxaline derivatives20189,856,234'Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors'20189,573,950'Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators'20179,540,376'Hexahydrodiazepinoquinolines carrying a substituted alkyl radical'20179,540,370'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors'20179,266,855'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors'20169,242,933'Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)'20169,169,253'Tricyclic quinoline and quinoxaline derivatives'20159,090,592'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors'20158,664,214'Small molecule potentiators of metabotropic glutamate receptors I'20148,642,598'Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors'20148,455,648'1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)'20138,318,793'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors'20128,314,120'Small molecule potentiators of metabotropic glutamate receptors'20127,994,160'Pyridazine compounds as glycogen synthase kinase 3 inhibitors'20117,501,418'Fused heterocyclic isoxazoline derivatives and their use as anti-depressants'20097,491,729'3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof'20097,465,741'C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants'20087,462,717'C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants'20087,265,103'Substituted amino isoxazoline derivatives and their use as anti-depressants'20077,169,786'Isoxazoline derivatives as anti-depressants'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2009Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2007–2009Based in Alsbach-Haehnlein, DE· patent location history
2007Based in Beerse, BE· patent location history
2009–2013Patents assigned to ABBOTT GMBH & CO KG (5)· patent assignee history
2009–2018Based in Seeheim-Jugenheim, DE· patent location history
2011–2018Based in Ludwigshafen, DE· patent location history
2012–2016Patents assigned to BAKKER MARGARETHA HENRICA MARIA (8)· patent assignee history
2012–2016Patents assigned to HORNBERGER WILFRIED (4)· patent assignee history
2014–2018Patents assigned to ABBVIE DEUTSCHLAND (13)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE DEUTSCHLAND | 13 | 2014–2018 |
| BAKKER MARGARETHA HENRICA MARIAself | 8 | 2012–2016 |
| ABBOTT GMBH & CO KG | 5 | 2009–2013 |
| HORNBERGER WILFRIED | 4 | 2012–2016 |
| JANSSEN PHARMACEUTICA NV | 4 | 2007–2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ludwigshafen, DE | 15 | 2011–2018 |
| Alsbach-Haehnlein, DE | 4 | 2007–2009 |
| Seeheim-Jugenheim, DE | 3 | 2009–2018 |
| Beerse, BE | 1 | 2007 |